Vivien Corporation (002070) Fair Value & Analysis
Consumer Cyclical · KR · Market cap 11.2B KRW
Fair value as of: Jul 22, 2026
From 12 valuation models · updated today
Share price +14.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 5,980 KRW – 24,000 KRW · fair‑value band 2,584 KRW – 16,536 KRW · the 7,420 KRW price screens above the 6,506 KRW fair value. As of Jul 22, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Vivien Corporation (002070) currently trades at 7,420 KRW, while our model-based Fair Value estimate is 6,506 KRW, implying the stock looks roughly 12.3% overvalued today. We read business quality at 33/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Vivien Corporation generated revenue of 215B KRW at a net margin of -8.4%. Revenue declined 13.2% year over year. It earns a return on equity of -7.6%. Net debt stands at 77.3B KRW. Fundamentals as of Jul 22, 2026
Our scenario range runs from 2,584 KRW (bear case) to 16,536 KRW (bull case); at 7,420 KRW, the current price sits within that range. The share trades about 47% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -1% fair-value upside, at -12%, 002070 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 22, 2026. TTM = trailing twelve months.
About the company
Vivien Corporation, together with its subsidiaries, manufactures women's underwear in South Korea. The company offers its products under the VIVIEN, BBM, Maternity, GENTOFF, SUVIVIEN, DELOR, Rosebud, and PANDORA brands. It sells its products through direct stores, department store, discount store, specialty store, and online shopping. The company was formerly known as Namyeung Vivien Corporation and changed its name to Vivien Corporation in August 2020. The company was founded in 1957 and is headquartered in Seoul, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Vivien Corporation reported revenue of 222B KRW in FY2025 versus 188B KRW in FY2021, a compound +4.3%/yr. Reported net income was −15.3B KRW in FY2025.
Is 002070 fairly valued? → Check now
Similar stocks
10 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| H & M Hennes & Mauritz AB HMB | kr 166.80 | kr 165.47 | -1% |
| Ralph Lauren Corporation RL | $376.43 | $423.69 | +13% |
| Moncler S.p.A MONC | €53.84 | €38.28 | -29% |
| Gildan Activewear Inc GIL | $58.41 | $37.01 | -37% |
| LPP SA LPP | 18,350 PLN | 20,063 PLN | +9% |
| Levi Strauss & Co LEVI | $23.61 | $16.83 | -29% |
| V.F. Corporation VFCO34 | R$43.24 | R$5.36 | -88% |
| Bosideng International Holdings 3998 | HK$4.44 | HK$5.92 | +33% |
| Youngor Fashion Co 600177 | ¥7.50 | ¥7.87 | +5% |
| Page Industries Limited PAGEIND | ₹38,345 | ₹9,665 | -75% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Vivien Corporation (002070) undervalued?
What is the fair value of 002070?
What is the quality score of 002070?
What is the revenue of Vivien Corporation (002070)?
What is the net profit margin of 002070?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Vivien Corporation analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.